Irsan Darmadji - Merck Sharp Insider

SCPI -- Indonesia Stock  

IDR 29,000  0.00  0.00%

Independent Commissioner

Dr. Irsan Budianto Darmadji serves as Independent Commissioner of PT Merck Sharp Dohme Pharma Tbk since December 19, 2011. He has served as a Commissioner of PT Candi Indah, PT Puri International Hotel, PT Putri Gundaling, PT Citra Rapi, PT Grahamas Citrawasata Tbk, PT Sarana Angakasa Transit Hotel, PT Dinar Securities, Creo Planner and PT Astrindo Pacific Finance. He holds MBA in International Business Management from University of San Francisco .
Age: 49  Executive Since 2011  MBA    

Management Efficiency

Similar Executives

Showing few of many executives

EXECUTIVE Since

Rohan HafasPT Bank Mandiri Tbk
2016
Nanan SoekarnaPT United Tractors Tbk
2015
Sigit WidyawanPT Bank Negara Indonesia Tbk
2018
Bangun KusmuljonoPT Bank Mandiri Tbk
2015
Anthony NightingalePT Astra International Tbk
2000
Makmur KeliatPT Bank Mandiri Tbk
2017
Sony KerafPT Bank Rakyat Indonesia Tbk
2015
Frank GelderPT Gudang Garam Tbk
2002
Tira ArdiantiPT Astra International Tbk
N/A
Zulkifli ZainiPT Bank Negara Indonesia Tbk
2015
Michinobu SugataPT Astra International Tbk
2016
Mark GreenbergPT Astra International Tbk
2006
Mahendra SiregarPT Unilever Indonesia Tbk
2015
Wahyu KuncoroPT Bank Negara Indonesia Tbk
2017
Jan HendraPT Bank Central Asia Tbk
2016
Bambang SubiantoPT Unilever Indonesia Tbk
2005
Hikmahanto JuwanaPT Unilever Indonesia Tbk
2011
Jeffry WurangianPT Bank Rakyat Indonesia Tbk
2015
Sonny KerafPT Bank Rakyat Indonesia Tbk
2015
Revrisond BaswirPT Bank Negara Indonesia Tbk
2016
Sidharta UtamaPT Astra International Tbk
2014

Entity Summary

Merck Sharp Dohme Pharma Tbk (SCPI) is traded on Jakarta Stock Exchange in Indonesia. and employs 5 people.

Merck Sharp Dohme Leadership Team

Christopher McNamara, Executive, CPA
Ashish Pal, President, MBA
Ardhi Pradhana, Executive, MBA
Novian Zein, Director
Ridarrahim Nirwandar, Executive
Meau Fon, Director
Erwin Agung, Director
Irsan Darmadji, Executive, MBA
Jan Acker, President
Cheung Ling, Director, MBA
YuhRu Chen, Director, CPA
Ekert Ann, Director

Stock Performance Indicators

Current Sentiment - SCPI

Merck Sharp Dohme Investor Sentiment
Macroaxis portfolio users are evenly split in their outlook on investing in Merck Sharp Dohme Pharma Tbk. What is your trading attitude regarding investing in Merck Sharp Dohme Pharma Tbk? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Trending Equities

Currently Active Assets on Macroaxis
OZL   
Purchased over 100 shares of
over a week ago
Traded for 10.44
FBU   
Purchased over 300 shares of
over a week ago
Traded for 6.24
JBH   
Purchased over 70 shares of
over a week ago
Traded for 23.42
GNC   
Purchased over 200 shares of
over a week ago
Traded for 8.1
SBM   
Purchased over 400 shares of
over a week ago
Traded for 4.74
Also please take a look at World Market Map. Please also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.